MarketLens

Pricing Plans Sign Up Log in

Stock Analysis Investment Ideas Pro

Eli Lilly's Growth Surge Justifies Öhman's Bold Healthcare Pivot

2 weeks ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Is Eli Lilly's Premium Valuation Justified by its Growth Story

4 months ago

Why is Eli Lilly Betting on Shingles Vaccines

2 months ago

Why Are Institutional Investors Still Bullish on Eli Lilly

4 months ago

What's Driving the Bearish Options Activity in Eli Lilly

4 months ago

Why Eli Lilly Gained 7% On Friday

Eli Lilly rose 7% on Friday, its biggest gain since February, after the company highlighted oncology and neuroscience developments that set it apart from peers.

LLY

Stock News•1 months ago

UnitedHealth, Eli Lilly Lead Healthcare Rebound as Investors Seek Stability

UnitedHealth and Eli Lilly lead a healthcare sector rebound as investors rotate into defensive stocks for stability.

UNH

Stock News•2 months ago

Silver Economy Investing: Why the Healthcare Giants Are in Focus

Healthcare leaders including Eli Lilly, Tandem Diabetes, Intuitive Surgical, and ResMed are targeting growth from aging-driven demand. These firms are focusing on obesity, surgical, and sleep care mar...

ABT

Stock News•2 months ago

GLP-1 Wars: Winners & Losers

Eli Lilly is establishing market dominance in the GLP-1 sector, leveraging its best-in-breed drug portfolio to capture significant share. This competitive positioning could solidify the company's long...

GLP